Use the Back button in your browser to see the other results of your search or to select another record.
Early physical rehabilitation therapy between 24 and 48 h following acute ischemic stroke onset: a randomized controlled trial [with consumer summary] |
Wang F, Zhang S, Zhou F, Zhao M, Zhao H |
Disability and Rehabilitation 2022;44(15)::3967-3972 |
clinical trial |
7/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: Yes; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
PURPOSE: Early mobilization is believed to be helpful for patients with acute ischemic stroke. This study aimed to compare the difference between starting rehabilitation between 24 and 48 h and 72 and 96 h following the onset of ischemic stroke. MATERIALS AND METHODS: This was a single-center, single-blind, randomized controlled trial. The early rehabilitation (ER) group started exercising between 24 and 48 h after stroke onset, which the standard rehabilitation (SR) group started exercising between 72 and 96 h. The two groups received sitting, standing, and repetitive body strength training respectively. RESULTS: In this study, 110 patients were analyzed. Patients in the early rehabilitation group had more favorable outcomes (the modified Rankin Scale score 0 to 2, ER group 32 versus SR group 20, adjusted odds ratio 2.27, 95% CI 1.05 to 4.87; p = 0.036) at 3-month follow-up. The simplified Fugl-Meyer assessment (FMA) scores for the lower extremity were influenced by the interaction effect (F = 7.24, p = 0.01). The post-hoc analysis revealed a difference in the lower extremity FMA score at one week after stroke (difference 2.30 (95% CI 0.65 to 3.96); p = 0.007). CONCLUSIONS: Early physical rehabilitation training between 24 and 48 h may be beneficial and improve patients' lower extremity function within the first week. CLINICAL TRIAL REGISTRATION UNIQUE IDENTIFIER: NCT02718534.
|